Abbott Laboratories (NYSE:ABT) will release its fiscal fourth-quarter earnings report next Thursday before the opening bell, setting up an intriguing idea for bullish options traders. Ordinarily, ABT stock would rate highly as a long-term investment anchor. A healthcare juggernaut, Abbott offers financial stability and a dividend. That makes it a darling for multi-year portfolio strategies, not necessarily for bare-knuckle profit scalping.However, while the market is off to a solid start in the new year, it ...